Welldoc, a digital healthcare pioneer that is revolutionizing chronic disease management, and Dexcom, the leader in real-time continuous glucose monitoring (CGM), announced today the first client for a new integrated offering designed to improve the health of people with Type 2 diabetes. Welldoc will include its BlueStar® digital health solution and the Dexcom G6 CGM system as a single platform offering for select employers and health systems, starting with a Fortune 100 company.
The Dexcom G6 system monitors glucose levels just under the skin's surface and wirelessly transmits data every five minutes. BlueStar®, an FDA-cleared digital health solution, lets users manage the difficult process of dealing with diabetes by empowering them to self-manage their conditions and enhancing connections to their healthcare teams.
“This collaboration enables us to put together for the first time the two most complicated, and often distinct, aspects of diabetes management – glucose monitoring and the effects of lifestyle choices. Users will be able to monitor different aspects of their health through a new app experience, while also enhancing data sharing with their care team,” said Kevin McRaith, CEO of Welldoc. “At Welldoc, our mission is to advance chronic condition self-management, improve population health, and reduce expenses. Our unified offering with Dexcom is a significant step forward in these efforts.”
“Throughout the pandemic, we saw the importance of Dexcom CGM for all people with diabetes. We also simplified and enhanced management for people living with Type 2 diabetes by combining CGM with engaging digital health solutions,” said Matt Dolan, senior vice president of strategy, corporate development, and new markets at Dexcom. “By integrating real-time CGM data and AI-driven digital health coaching, our extended collaboration with Welldoc will encourage clients to take care of their health.”
The G6 includes a small, water-resistant sensor that is discreet, simple to insert, and FDA-cleared to make diabetes care decisions without the need for confirmatory fingersticks or calibration. The app includes customizable alarms and reminders to warn users about unsafe glucose levels even when they are sleeping.
Welldoc® is transforming chronic disease management to help people live better lives. BlueStar®, an FDA-cleared digital health solution, helps people manage the difficult journey of living with diabetes by empowering them to self-manage their conditions and improving connections to their healthcare team. Welldoc simplifies the interactions between payers, employers, and healthcare system resources, intending to improve population health and minimize chronic disease costs.